1 study found for:    NCT00216281
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Clozapine augmented with atomoxetine up to 40 mg or placebo

Indicates status has not been verified in more than two years